Alexandria Pharmaceuticals results, Fiscal year 2020
Net profit, assets, equity and cash flow for Fiscal year 2020, against the same period a year earlier, from the published financial statements. fiscal year starts in July.
Net profit170 millionEGP
Total assets799 millionEGP
Shareholders' equity572 millionEGP
Operating cash flow140 millionEGP
In short
- Alexandria Pharmaceuticals's net profit for Fiscal year 2020 was about 170 million EGP.
- Total assets at the end of Fiscal year 2020 were about 799 million EGP, and shareholders' equity about 572 million EGP.
- Operating cash flow for Fiscal year 2020 was positive at 140 million EGP.
Key lines against the same period a year earlier
This periodYear earlierChange
Net profit170 million——
Gross profit344 million——
Total assets799 million——
Total liabilities227 million——
Shareholders' equity572 million——
Total liabilities and equity799 million——
Operating cash flow140 million——
Investing cash flow-60.02 million——
Financing cash flow-78.08 million——
Net change in cash1.7 million——
Figures in EGP from the published statement summaries (consolidated where the company publishes consolidated statements), after normalising reporting units across periods. The exact figure is in the attached report, which may be the standalone version.
Alexandria Pharmaceuticals's Q1 2027 results, the day they are published
One email on the day, no account, and a one-click stop in the email itself.
By subscribing you agree to receive these alerts only. Privacy policy